Dr. Patrick Walsh answers the question: 'Perineal Vs. Retropubic Approach?' March 16, 2009 -- Question: What are the differences between a radical perineal prostatectomy and a radical retropubic ...

Dr. Guru answers the question: 'What Is A Radical Retropubic Prostectomy?' March 16, 2009 -- Question: What is a radical retropubic prostatectomy? Answer: A radical retropubic prostatectomy is one of ...

At 24 months' follow-up, the only phase 3 randomized clinical trial to directly compare functional and oncologic outcomes between robot-assisted laparoscopic prostatectomy and open radical retropubic ...

The most common surgery for prostate cancer is a radical prostatectomy. This surgery involves taking out the entire prostate gland, some lymph nodes and other nearby tissue, like the seminal vesicles ...

May 2, 2012 — Robot-assisted laparoscopic radical prostatectomy (RALP) is at least equivalent to other surgical approaches in terms of outcome in the short term, and might provide advantages such as ...

A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell ...

Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors (E9897): A Trial of the Eastern Cooperative Oncology Group PURPOSE: To assess the effect of nerve-sparing (NS) radical ...

Stereotactic body radiotherapy as salvage therapy after radical prostatectomy was well tolerated. Toxic effects were comparable to a historical cohort of patients receiving conventionally fractionated ...

ORLANDO – Robotic-assisted laparoscopic prostatectomy (RALP) is associated with significantly higher costs than laparoscopic prostatectomy (LRP) or open radical retropubic prostatectomy (RRP), yet the ...

Up to 72% of patients with prostate cancer who undergo radical prostatectomy experience urinary incontinence in the first 3 months after surgery. Patients with postoperative urinary incontinence after ...

A 10-year follow-up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision-making in terms of treatments and side effects for a diverse population.